2-Bromo-5-chloro-4-cyclopropylpyridine

Catalog No.: 
ACBSGZ444
CAS No.: 
1934500-72-7
Molecular Formula: 
C8H7BrClN
Molecular Weight: 
232.51
2-Bromo-5-chloro-4-cyclopropylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%
100mg95%
250mg95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-5-chloro-4-cyclopropylpyridine
IUPAC Name2-bromo-5-chloro-4-cyclopropylpyridine
MDL No.MFCD29033806
Molecular FormulaC8H7BrClN
Molecular Weight232.51
SMILESClC1=CN=C(Br)C=C1C2CC2
InChI KeyBAQYBXBSBUNXTF-UHFFFAOYSA-N
Synonym2-Bromo-5-chloro-4-cyclopropylpyridine;Pyridine, 2-bromo-5-chloro-4-cyclopropyl-
CAS No.1934500-72-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBSGZ444 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMBRG053 route compound structure diagram
    ACMBRG053875232-70-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBSGZ444 route product structure diagram
    ACBSGZ4441934500-72-7
Inquiry

2. ACBSGZ444 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJZGN469 route compound structure diagram
    ACJZGN4691033203-42-7In Stock
  4. Then
  5. ACBSGZ444 route product structure diagram
    ACBSGZ4441934500-72-7
Inquiry

3. ACBSGZ444 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBSGZ444 route product structure diagram
    ACBSGZ4441934500-72-7
Inquiry

Comments (0)